Lv1
60 积分 2024-02-26 加入
A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors
1天前
已完结
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
2天前
已完结
Selective Inhibitors of Histone Deacetylase 10 (HDAC-10)
4天前
已完结
HDAC-targeting epigenetic modulators for cancer immunotherapy
5天前
已完结
Discovery of a Novel Benzimidazole Derivative Targeting Histone Deacetylase to Induce Ferroptosis and Trigger Immunogenic Cell Death
8天前
已完结
Fullerenols as efficient ferroptosis inhibitor by targeting lipid peroxidation for preventing drug-induced acute kidney injury
8天前
已完结
Type I [4σ+4π] versus [4σ+4π−1] Cycloaddition To Access Medium‐Sized Carbocycles and Discovery of a Liver X Receptor β‐Selective Ligand
9天前
已完结
Simultaneous Inhibition of FLT3 and HDAC by Novel 6-Ethylpyrazine-2-Carboxamide Derivatives Provides Therapeutic Advantages in Acute Myelocytic Leukemia
14天前
已完结
Tunable multi-responsive N-heterocyclic carbene-gold nanoenzyme for tumor-specific pyroptosis and immune activation in cancer therapy
14天前
已完结
Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity
1个月前
已完结
皖公网安备34019202002308
